can 503a pharmacies still compound tirzepatide Compounded Availability 2024 Compounded Tirzepatide for Weight Loss

Our evidence review of peptide safety and clinical applications for weight loss covers this candidacy question in more depth

However, if you meet the medical criteria for obesity treatment, BCBS may approve Wegovy , the semaglutide version designed for weight loss

However, tirzepatide may not be suitable for individuals with certain medical histories, such as pancreatitis, medullary thyroid carcinoma, or severe gastrointestinal disorders

The FDA maintains a black-box warning for patients with personal or family MTC or MEN2 history, but for others, thyroid cancer risk from semaglutide remains theoretical

A patient using a legitimate compounded program in the $200 to $250 monthly range, which is roughly where Medura's plan sits, is looking at closer to $1,200 to $1,500 for that same six-month period, consultation and shipping included, with no separate fees layered on top